Zhang FJ, Fang WJ, Zhang CJ. Monomorphic epitheliotropic intestinal T-cell lymphoma with bone marrow involved: A case report. World J Clin Cases 2024; 12(4): 814-819 [PMID: 38322688 DOI: 10.12998/wjcc.v12.i4.814]
Corresponding Author of This Article
Wen-Juan Fang, MD, Nurse, Department of Hematology, Lishui Municipal Central Hospital, No. 289 Kuocang Road, Lishui 323000, Zhejiang Province, China. fang_vicky003@163.com
Research Domain of This Article
Hematology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Feb 6, 2024; 12(4): 814-819 Published online Feb 6, 2024. doi: 10.12998/wjcc.v12.i4.814
Monomorphic epitheliotropic intestinal T-cell lymphoma with bone marrow involved: A case report
Fen-Juan Zhang, Wen-Juan Fang, Cang-Jian Zhang
Fen-Juan Zhang, Wen-Juan Fang, Cang-Jian Zhang, Department of Hematology, Lishui Municipal Central Hospital, Lishui 323000, Zhejiang Province, China
Author contributions: Fang WJ designed the report and wrote the paper; Zhang FJ and Zhang CJ revised the paper; and all authors have read and approved the final version of this manuscript.
Supported byZhejiang Province Traditional Chinese Medicine Science and Technology Project, No. 2024ZL1296.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Juan Fang, MD, Nurse, Department of Hematology, Lishui Municipal Central Hospital, No. 289 Kuocang Road, Lishui 323000, Zhejiang Province, China. fang_vicky003@163.com
Received: October 9, 2023 Peer-review started: October 9, 2023 First decision: November 28, 2023 Revised: December 8, 2023 Accepted: January 8, 2024 Article in press: January 8, 2024 Published online: February 6, 2024 Processing time: 107 Days and 18.5 Hours
Abstract
BACKGROUND
Monomorphic epithelial intestinal T-cell lymphoma (MEITL) is a rare type of peripheral T-cell lymphoma. The clinical manifestations are diarrhea, abdominal pain, perforation and an abdominal mass.
CASE SUMMARY
We present a 52-year-old female patient who was diagnosed with MEITL. Further disease progression was observed after multiline chemotherapy. Eventually, the patient died of a severe infection.
CONCLUSION
MEITL is a rare intestinal primary T-cell lymphoma with aggressive behavior, a high risk of severe life-threatening complications, and a poor prognosis.
Core Tip: This article reports a patient diagnosed with monomorphic epithelial intestinal T-cell lymphoma (MEITL). Further disease progression was observed after multiline chemotherapy. Eventually, the patient died of a severe infection. MEITL is a rare intestinal primary T-cell lymphoma with aggressive behavior, a high risk of severe life-threatening complications, and a poor prognosis.
